Brian Gazaille on Muck Rack

Brian Gazaille

Verified
(He/Him)
Eugene
As seen in: BioProcess International Magazine
Covers:  Biopharmaceutical development and manufacturing, antibodies, mAbs, vaccines, mRNA, viral vectors, cell and gene therapies

Get in touch with Brian

Contact Brian, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Articles

eBook: Bioconjugates — Extending the Logic of Targeted Drug Delivery

|
By Brian Gazaille , Sung Lee
| BioProcess International Magazine
After a few decades of occasional commercial successes tempered by clinical setbacks, antibody–drug conjugates (ADCs) finally have hit their stride. Between 2020 and 2025, regulatory agencies approved eight such products — more than had received approval in the 20 years preceding. Having cleared initial hurdles attributable to molecular instability and immature linker technologies, drug companies are bringing many candidate ADCs into clinical studies.
Open in Who Shared Issue with article?

Fujifilm Cellular Dynamics Boosts Stem-Cell Capacity at New Madison Site

|
By Brian Gazaille 
| BioProcess International Magazine
Fujifilm Cellular Dynamics (FCDI), a global manufacturer of human induced pluripotent stem cell (iPSCs) and service provider for stem-cell applications, has launched a new facility in its hometown of Madison, Wisconsin. Bearing some of the fruits from a US$200 million strategic investment by Fujifilm Corporation in December 2023, the 175,000-ft2 building is designed to integrate cutting-edge capabilities for cell culture and process development as well as a gene editing center of excellence.
Open in Who Shared View Duplicates (35) Issue with article?

Sung Joo Lee | BioProcess International

|
By Sung Lee, Brian Gazaille 
| BioProcess International Magazine
Allogeneic therapies based on healthy-donor material should help to create scalable processes for “off-the-shelf” drugs, potentially reducing production costs and increasing accessibility, however, developers of allogeneic products also must answer practical questions about where to obtain starting material and how to ensure its quality. This eBook explores solutions for cell sourcing, characterization, and quality control.
Open in Who Shared Issue with article?
See all 92 articles

Actions

Share this page

Get in touch with Brian

Contact Brian, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified